Abstract
The prevalence of allergy and asthma has been increasing steadily in the developed world. Despite the growing health problems associated with these conditions few new therapeutic options are becoming available. Relatively recent developments have identified a role for proteases in promoting allergic sensitisation and allergic airway inflammation. It is also known that most major allergens have associated protease activity that is closely related to their efficacy to induce sensitization and inflammation. Here we review the evidence for the significance of protease activity in allergic airway disease and offer suggestions as to where the field could progress.
Keywords: Asthma, allergen, serine proteases, protease-activated receptors, allergic inflammation
Inflammation & Allergy - Drug Targets (Discontinued)
Title: Should we Target Allergen Protease Activity to Decrease the Burden of Allergic Airway Inflammation?
Volume: 7 Issue: 4
Author(s): Harissios Vliagoftis and Paul Forsythe
Affiliation:
Keywords: Asthma, allergen, serine proteases, protease-activated receptors, allergic inflammation
Abstract: The prevalence of allergy and asthma has been increasing steadily in the developed world. Despite the growing health problems associated with these conditions few new therapeutic options are becoming available. Relatively recent developments have identified a role for proteases in promoting allergic sensitisation and allergic airway inflammation. It is also known that most major allergens have associated protease activity that is closely related to their efficacy to induce sensitization and inflammation. Here we review the evidence for the significance of protease activity in allergic airway disease and offer suggestions as to where the field could progress.
Export Options
About this article
Cite this article as:
Vliagoftis Harissios and Forsythe Paul, Should we Target Allergen Protease Activity to Decrease the Burden of Allergic Airway Inflammation?, Inflammation & Allergy - Drug Targets (Discontinued) 2008; 7 (4) . https://dx.doi.org/10.2174/187152808786848379
DOI https://dx.doi.org/10.2174/187152808786848379 |
Print ISSN 1871-5281 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4055 |
Related Articles
-
Biologics for the Treatment of Juvenile Idiopathic Arthritis
Current Medicinal Chemistry Wasp Venom Toxins as a Potential Therapeutic Agent
Protein & Peptide Letters Genomics of Chronic Obstructive Pulmonary Disease (COPD); Exploring the SNPs of Protease-Antiprotease Pathway
Current Genomics Inflammatory Mechanisms of Adverse Reactions to Drug-Eluting Stents
Current Vascular Pharmacology Negative Air Ions in Neuropsychiatric Disorders
Current Medicinal Chemistry A Review of Pharmacological Treatment Options for Lung Cancer: Emphasis on Novel Nanotherapeutics and Associated Toxicity
Current Drug Targets Biochemical and Molecular Biological Aspects of Silverfish Allergens
Protein & Peptide Letters Past Efforts and Future Prospects for a Nasal Influenza Vaccine
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Anatomical and Functional Relationships Between Sensory Nerves and Mast Cells
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Topical Delivery of Steroids in Inflammatory Bowel Disease
Current Drug Delivery Appropriate Use of Antibiotics for the Management of Respiratory Tract Infections
Infectious Disorders - Drug Targets Extraction of 11-Keto-β -Boswellic Acid from Indian Olibanum by Contemporary Extraction Modes: Optimization and Validation of HPTLC
Combinatorial Chemistry & High Throughput Screening Therapies in Development for Non-Infectious Uveitis
Current Molecular Medicine Surfactant Protein (SP)-A and SP-D as Antimicrobial and Immunotherapeutic Agents
Recent Patents on Anti-Infective Drug Discovery Dextran-based Nanocarriers for Delivery of Bioactives
Current Pharmaceutical Design Integrins in Pulmonary Inflammatory Diseases
Current Pharmaceutical Design The Neuropathology of Vascular Disease in the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS)
Current Alzheimer Research Patent Perspective for Potential Antioxidant Compounds-Rutin and Quercetin
Recent Patents on Nanomedicine Use of Antihistamines in Ocular Therapy
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Adalimumab <i>versus</i> Infliximab Treatment Outcome in Ulcerative Colitis: Application of EQ-5D, Visual Analogue Scale, and IBDQ-9 Measures: A Prospective Observational Study
Current Drug Safety